• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Surgery for advanced breast cancer from the viewpoint of medical oncologist].

作者信息

Ono Makiko, Fujiwara Yasuhiro

机构信息

Department of Breast and Medical Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan.

出版信息

Gan To Kagaku Ryoho. 2007 Jun;34(6):858-61.

PMID:17565247
Abstract

The incidence of breast cancer is increasing among Japanese women. It is an important issue to prevent breast cancer and develop therapy for it. Breast cancer is recognized as a systemic disease due to early micrometastases, and multimodality treatment is needed. Development of newer and more effective chemotherapy and hormone therapy contributes to improvement in survival for breast cancer patients. But the optimal treatment for locally advanced breast cancer is still not established. Here we describe multimodality treatment to clarify the role of each modality, especially surgery for locally advanced and metastatic breast cancer.

摘要

相似文献

1
[Surgery for advanced breast cancer from the viewpoint of medical oncologist].
Gan To Kagaku Ryoho. 2007 Jun;34(6):858-61.
2
Docetaxel followed by fluorouracil/epirubicin/cyclophosphamide as neoadjuvant chemotherapy for patients with primary breast cancer.多西他赛序贯氟尿嘧啶/表柔比星/环磷酰胺新辅助化疗治疗原发性乳腺癌患者。
Jpn J Clin Oncol. 2011 Jul;41(7):867-75. doi: 10.1093/jjco/hyr081.
3
Neoadjuvant treatment in young women with breast cancer.年轻乳腺癌女性的新辅助治疗。
Breast Cancer Res Treat. 2010 Sep;123 Suppl 1:35-8. doi: 10.1007/s10549-010-1040-7. Epub 2010 Aug 14.
4
Can early response assessment guide neoadjuvant chemotherapy in early-stage breast cancer?早期反应评估能否指导早期乳腺癌的新辅助化疗?
J Natl Cancer Inst. 2008 Apr 16;100(8):521-3. doi: 10.1093/jnci/djn098. Epub 2008 Apr 8.
5
[Primary systemic therapy in breast cancer patients (2007-2010)].[乳腺癌患者的初始全身治疗(2007 - 2010年)]
Magy Seb. 2011 Oct;64(5):223-8. doi: 10.1556/MaSeb.64.2011.5.1.
6
Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.在接受多柔比星和环磷酰胺序贯紫杉醇辅助化疗的III期乳腺癌患者中,bcl-2表达的预后意义
BMC Cancer. 2007 Apr 12;7:63. doi: 10.1186/1471-2407-7-63.
7
[Importance of dose intensity in chemotherapy--lessons from adjuvant chemotherapy for early breast cancer].[化疗中剂量强度的重要性——早期乳腺癌辅助化疗的经验教训]
Rinsho Ketsueki. 2009 Apr;50(4):276-81.
8
Adjuvant capecitabine, docetaxel, cyclophosphamide, and epirubicin for early breast cancer: final analysis of the randomized FinXX trial.卡培他滨、多西他赛、环磷酰胺和表柔比星辅助治疗早期乳腺癌:FinXX 试验的最终随机分析。
J Clin Oncol. 2012 Jan 1;30(1):11-8. doi: 10.1200/JCO.2011.35.4639. Epub 2011 Nov 21.
9
High pathologic complete response in HER 2-positive locally advanced breast cancer after primary systemic chemotherapy with weekly docetaxel and epirubicin.在接受每周一次多西他赛和表柔比星的原发性全身化疗后,HER 2阳性局部晚期乳腺癌患者出现高病理完全缓解。
Jpn J Clin Oncol. 2008 Feb;38(2):99-105. doi: 10.1093/jjco/hym172. Epub 2008 Feb 12.
10
Infusional fluorouracil, epirubicin, and cisplatin followed by weekly paclitaxel plus bevacizumab in locally advanced breast cancer with unfavorable prognostic features.对于具有不良预后特征的局部晚期乳腺癌患者,采用氟尿嘧啶、表柔比星和顺铂持续静脉滴注,随后每周给予紫杉醇加贝伐单抗治疗。
Anticancer Drugs. 2009 Mar;20(3):197-203. doi: 10.1097/CAD.0b013e3283264719.